- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 306
Northern Biologics and Mosaic Biomedicals shape merger
Celgene-backed antibody therapy developer Northern Biologics has extended its series A round and merged with oncology treatment developer Mosaic Biomedicals.
Dec 20, 2016Astellas investment gets Oncorus to $61m
A $4m investment by pharmaceutical company Astellas's corporate venturing unit has been added to the $57m Oncorus raised from backers including Celgene in July.
Dec 19, 2016Horizn Studios bags series A capital
Vorwek-backed travel accessory manufacturer Horizn Studios has raised several million dollars in its series A round to expand internationally, beginning with the UK.
Dec 16, 2016Inke and FunPlus make Next move
Next Entertainment, a live video streaming platform curated by livestreaming company Inke and game developer FunPlus, has raised $25m in a series A round.
Dec 16, 2016BillFront rings up $35m
Fintech company BillFront has raised a combination of series A equity and debt from strategic investors NIBC Bank and 4Finance as well as existing shareholder Finleap.
Dec 15, 2016Signal filters $7.4m for series A round
AI-powered media analysis startup Signal Media has raised new funding from investors including Hearst Media and RELX, after securing seed capital last year.
Dec 15, 2016Lola latches on to $7m
The organic tampon provider, which has raised $10m in 2016, secured funding from investors including the AOL-backed BBG Ventures.
Dec 14, 2016About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


